Hemophiliacs run high risk of blood clots from implanted catheters, UT Southwestern study reveals

September 06, 2001

DALLAS - Despite hemophilia's persistent threat of prolonged bleeding, children with the disease run a high risk of developing dangerous internal blood clots from long-term central venous catheter implants, according to research at UT Southwestern Medical Center at Dallas.

A clinical study of 15 boys, aged 4 to 14, with severe hemophilia found they had at least a 50 percent chance of developing a blood clot, known as deep venous thrombosis, linked to a catheter implanted under the skin for 12 months or longer. Eight of the boys had developed deep blood clots in the veins near their hearts, according to the study. The findings will appear in the Sept. 15 issue of Blood, the journal of the American Society of Hematology.

Adults with similar implants are also at risk, the scientists said.

This first-of-a-kind study raises serious doubts about the long-term safety of catheters implanted for routine injection of the absent blood-clotting factors in hemophilia patients - a therapy commonly prescribed for more than a decade, said Dr. George Buchanan, professor of pediatrics, director of the pediatric oncology/hematology program within the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern and senior author of the study.

"At best, it says that we have to seriously consider the risks and the benefits of using a catheter long term," said Dr. Janna M. Journeycake, a fellow in pediatric hematology/oncology and principal investigator on the project.

Buchanan said the results also raise serious questions about the safety of long-term implanted catheter use for intravenous injection of any medication or for nutrition support.

The devices are known to cause major risks of infection in hemophiliacs and other patients and to cause internal blood clots in cancer patients receiving chemotherapy.

Buchanan said studies of catheter-induced blood clots in hemophiliacs are lacking, most likely because of the paradox that individuals with such bleeding disorders might develop clots. In 1998, he studied 13 hemophilia patients for the same possible hazards, but with shorter-term catheter implants. In that study, none of the 13 boys with catheters in place for 10 months to five years showed evidence of deep venous thrombosis.

Buchanan and Journeycake said they extended the inquiry because they had recently detected blood clots in several of their hemophilia patients. Although not focused on catheters, other case studies also had indicated that blood clots can form in hemophilia patients, said Buchanan, also director of the Center for Cancer and Blood Disorders at Children's Medical Center of Dallas.

In the latest study, each of the 15 boys was examined with contrast venography, a form of radiography. A venogram was developed by inserting an IV line into an arm vein. A contrast medium, a dye-like liquid, was injected through the IV hookup.

Journeycake said a radiologist used real-time X-ray technology, known as fluoroscopy, to film the path of the colored medium through the veins. The film was read immediately to view the vein's "vessel architecture" for possible clots forming.

The results, she said, included finding three patients with more than one deep blood clot.

Buchanan said it will be tough for patients, patients' families and doctors alike to forgo the convenience of catheters and find safer alternatives for long-term therapy.

In the United States, hemophilia sufferers number between 17,000 and 20,000, and incidence-rate estimates put the disease occurring in one out of every 5,000 to 7,500 boys born, according to medical handbooks.
Dr. Charles T. Quinn, assistant professor of pediatrics at UT Southwestern, and Kim L. Miller and Joy L. Zajac, clinical pediatric nurse practitioners and hemophilia nursing coordinators at Children's, were also on the research team.

The study was funded by the National Institutes of Health, the Maternal and Child Health Bureau, the Centers for Disease Control and Prevention, and Children's Cancer Fund of Dallas.

UT Southwestern Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.